Cancer Immunotherapy Gathers in Phoenix: Eight Studies at SITC 2026 Target Resistance, Brain Tumors
· techtimes.com · popularity 20/100 · 0 similar stories today · Cancer & Oncology (Health & Life Sciences)
Read the original at techtimes.com →
Summary
Cancer immunotherapy conference 2026 delivers eight late-breaking studies at SITC 41st Annual Meeting in Phoenix, November 4-8, exploring CAR-T for pediatric brain tumors, reformulated TIL therapy for melanoma, next-generation cytokines, and bispecific antibodies for lung cancer - all targeting the checkpoint-resistant patients immunotherapy has yet to reach.
Found in: Tech Times. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 5.